Vitamin D-binding protein polymorphisms are not associated with development of (multiple) basal cell carcinomas

Experimental Dermatology

Volumn 19, Issue 12, 2010, Pages 1103-1105

  Flohil, Sophie C ^a   De Vries, Esther ^a   Van Meurs, Joyce B J ^a   Fang, Yue ^a   Stricker, Bruno H Ch ^a   Uitterlinden, André G ^a   Nijsten, Tamar ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Age gene interaction; Basal cell carcinoma (BCC); Polymorphism; Vitamin D binding protein (VDBP)

Indexed keywords

VITAMIN D BINDING PROTEIN;

ADULT; AGED; AGING; BASAL CELL CARCINOMA; CANCER SUSCEPTIBILITY; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PROPORTIONAL HAZARDS MODEL; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN CARCINOMA;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; VITAMIN D-BINDING PROTEIN;

EID: 78649519478     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2010.01139.x     Document Type: Letter

References (25)

1. De Vries E, Van De Poll-Franse L V, Louwman W J, De Gruijl F R, Coebergh J W. Br J Dermatol 2005: 152: 481-488.
2. Rubin A I, Chen E H, Ratner D. N Engl J Med 2005: 353: 2262-2269.
3. De Vries E, Louwman M, Bastiaens M, De Gruijl F, Coebergh J W. J Invest Dermatol 2004: 123: 634-638.
4. Han J, Kraft P, Colditz G A, Wong J, Hunter D J. Int J Cancer 2006: 119: 1976-1984.
5. Stacey S N, Sulem P, Masson G et al. Nat Genet 2009: 41: 909-914.
6. Gandini S, Raimondi S, Gnagnarella P, Dore J F, Maisonneuve P, Testori A. Eur J Cancer 2009: 45: 634-641.
7. Rafnar T, Sulem P, Stacey S N et al. Nat Genet 2009: 41: 221-227.
8. Wilkening S, Hemminki K, Rudnai P et al. Br J Dermatol 2006: 155: 1139-1144.
9. Stacey S N, Sulem P, Masson G et al. Nat Genet 2009: 41: 909-14.
10. Stacey S N, Gudbjartsson D F, Sulem P et al. Nat Genet 2008: 40: 1313-1318.
11. Brudnik U, Branicki W, Wojas-Pelc A, Kanas P. Exp Dermatol 2009: 18: 167-174.
12. Deeb K K, Trump D L, Johnson C S. Nat Rev Cancer 2007: 7: 684-700.
13. Jenab M, Bueno-de-Mesquita H B, Ferrari P et al. BMJ 340:b5500.
14. Woolcott C G, Wilkens L R, Nomura A M et al. Cancer Epidemiol Biomarkers Prev 2010: 19: 130-134.
15. Asgari M M, Tang J, Warton M E et al. J Invest Dermatol 2009: 130: 1438-43.
16. Ramachandran S, Fryer A A, Lovatt T J et al. Cancer Lett 2003: 189: 175-181.
17. Arnaud J, Constans J. Hum Genet 1993: 92: 183-188.
18. Sinotte M, Diorio C, Berube S, Pollak M, Brisson J. Am J Clin Nutr 2009: 89: 634-640.
19. Lauridsen A L, Vestergaard P, Nexo E. Clin Chem 2001: 47: 753-756.
20. Fang Y, Van Meurs J B, Arp P et al. Calcif Tissue Int 2009: 85: 85-93.
21. Pani M A, Regulla K, Segni M et al. J Clin Endocrinol Metab 2002: 87: 2564-2567.
22. Abbas S, Linseisen J, Slanger T et al. Cancer Epidemiol Biomarkers Prev 2008: 17: 1339-1343.
23. Hofman A, Breteler M M, Van Duijn C M et al. Eur J Epidemiol 2007: 22: 819-829.
24. Corder E H, Friedman G D, Vogelman J H, Orentreich N. Cancer Epidemiol Biomarkers Prev 1995: 4: 655-659.
25. Kiiski V, De Vries E, Flohil S C et al. Arch Dermatol 2010: (accepted for publication).